ethambutol has been researched along with norfloxacin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bhakta, S; Boshoff, HI; Evangelopoulos, D; Gibbons, S; Gunaratnam, M; Lenaerts, A; Malkinson, JP; Moreira, JB; Neidle, S; O'Donnell, G; Poeschl, R; Zimhony, O | 1 |
| Gibbons, S; Paton, A; Skelton, BW; Stavri, M | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Curry, J; Gibbons, S; Malkinson, JP; Rahman, MM; Shiu, WK; Stapleton, P; Zloh, M | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN | 1 |
| Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
| Hoffner, SE; Källenius, G; Kratz, M; Olsson-Liljequist, B; Svenson, SB | 1 |
| Chung, GA; Piddock, LJ; Williams, KJ | 1 |
| Chen, Z; Wang, H | 1 |
| Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
2 review(s) available for ethambutol and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
12 other study(ies) available for ethambutol and norfloxacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Bioactive pyridine-N-oxide disulfides from Allium stipitatum.
Topics: 2,2'-Dipyridyl; Alkaloids; Allium; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Disulfides; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heat-Shock Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Molecular Structure; Oxyquinoline; Pyridines; Thioredoxins; Vitamin K 3 | 2009 |
Antibacterial diterpenes from Plectranthus ernstii.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Diterpenes; Drug Resistance, Multiple; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plectranthus; Stereoisomerism; United Kingdom | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antibacterial acylphloroglucinols from Hypericum olympicum.
Topics: Anti-Bacterial Agents; Hypericum; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phloroglucinol; Staphylococcus aureus | 2012 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea | 2016 |
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles | 2017 |
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Norfloxacin; Ofloxacin | 1989 |
Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.
Topics: Anti-Infective Agents; Antimetabolites; Culture Media; Ethambutol; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium; Norfloxacin; Polysorbates | 1998 |
[Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; L Forms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Norfloxacin; Rifampin; Streptomycin | 2001 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |